Rheinland invested 148 million US dollars to build a plant and expand the production of sweeteners by 4,000 tons every year!
Layn Natural Ingredients, an expert in plant extracts, announced an investment of US$148 million for infrastructure expansion, promotion of plant extracts and natural sweeteners innovation and R&D, and consolidation of the supply chain.
The investment project includes a new production facility, which is expected to be completed within three years, and will increase the production of 4,000 tons of stevia leaf extract per year.
As the first listed company in the domestic plant extraction industry, Rheinland mainly produces natural sweetener extracts of stevia and Luo Han Guo, sweet tea extracts, and various functional Plant Extracts, such as Centella asiatica and rosemary. Rhein stated that the move is aimed at meeting the growing global demand for natural sweeteners and plant ingredients rich in polyphenols.
At the same time, the company will invest funds to establish innovation centers in Asia, Europe and the United States, provide formulation and R&D support for global manufacturing partners, and promote the discovery of new plant extracts and specific plant compounds. The company also plans to expand its sustainable agronomy innovation program to expand a transparent and traceable supply chain.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Unilever's Bold Move: Shifting the Paradigm in Ice Cream Storage
-
The steady growth in the Development Ansaimi, sucralose and steviol glycosides
-
Global Sweetener Innovation Trends
-
Global View of Sweetener Market Size
-
US Chemical Shutdown Wave Expands, PS Units Become the Hardest Hit Segment
-
Brenntag Partners with Givaudan to Supply Active Cosmetic Ingredients and Raw Materials to Thailand
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
One Ton of Fake Plastic Nearly Burned China’s Manufacturing Reputation—Wanhua Chemical Exposes the Underbelly of the Chemical Black Market
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
Recommend Reading
-
Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
-
Toray to Transfer Stake in Soda Aromatic to Samyang
-
Hormuz Crisis Pushes Up Urea Prices as Yara’s Quarterly EBITDA Jumps 39%
-
Dow and Celanese Retreat: European and Korean Cutbacks as China Expands
-
Wanhua Chemical Is Fighting Counterfeits While Raising Prices
-
Cost-Driven: October Polyester Staple Fiber Prices First Drop, Then Rise
-
Strong Cost Support Drives Continued Strength in PTA Prices
-
Natural Rubber Market Trends Have Been Volatile and Consolidating Since July
-
Crude Oil Volatility Still Dominates; PTA Prices Overall Remain on a Downward Trend
-
Cyclohexane Market Supply and Demand Balance, Prices Remain Stable